Focus on personalized medicine and the MetAction study

Gunhild Mlandsmo (left) and Kjersti Flatmark
Gunhild Mlandsmo (left) and Kjersti Flatmark

The Norwegian Cancer Society have recently published a popular science article (in Norwegian) presenting the work of Gunhild Mælandsmo and Kjersti Flatmark, both from the Department of Tumor Biology at the Institute for Cancer Research. The scientists explains how their research on colorectal cancer may improve the methods of personalized medicine, and how the MetAction study, which is supported by the Norwegian Cancer Society, may contribute to the development of more precise cancer treatments in the future.

Links:

Article from the Norwegian Cancer Society (Kreftforeningen):
Legger grunnlaget for framtidens presisjonsbehandling

Home page of Gunhild Mælandsmo's group - Metastasis Biology and Therapy

Home page of Kjersti Flatmark's group - Translational Cancer Therapy

Department of Tumor Biology